Free Trial

Curaleaf (OTCMKTS:CURLF) Trading Down 3.5% - Should You Sell?

Curaleaf logo with Medical background

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s share price was down 3.5% on Friday . The stock traded as low as $0.78 and last traded at $0.80. Approximately 362,163 shares were traded during trading, a decline of 10% from the average daily volume of 402,714 shares. The stock had previously closed at $0.83.

Curaleaf Stock Down 2.8%

The company has a current ratio of 1.41, a quick ratio of 0.70 and a debt-to-equity ratio of 1.08. The stock has a 50-day simple moving average of $0.86 and a 200-day simple moving average of $1.10. The company has a market cap of $543.97 million, a price-to-earnings ratio of -2.65 and a beta of 0.62.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.07). Curaleaf had a negative net margin of 17.37% and a negative return on equity of 14.12%. As a group, analysts predict that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Featured Articles

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines